KIF2C and Alzheimer disease: Interestingly, Oligomeric amyloid-β directly inhibits the MT-dependent ATPase activity of KIF2C in vitro, and thereby leads to the generation of defective mitotic structures which may contributes to the development of Alzheimer’s disease (Borysov et al., 2011).